6D0U image
Deposition Date 2018-04-11
Release Date 2019-01-16
Last Version Date 2024-10-09
Entry Detail
PDB ID:
6D0U
Title:
Crystal structure of C05 V110P/A117E mutant bound to H3 influenza hemagglutinin, HA1 subunit
Biological Source:
Source Organism:
Influenza A virus (Taxon ID: 506350)
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.25 Å
R-Value Free:
0.26
R-Value Work:
0.25
R-Value Observed:
0.25
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Hemagglutinin
Gene (Uniprot):HA
Chain IDs:A, D (auth: B), G (auth: J), L (auth: G)
Chain Length:274
Number of Molecules:4
Biological Source:Influenza A virus
Polymer Type:polypeptide(L)
Molecule:Antibody C05 V110P/A117E mutant, heavy chain
Chain IDs:B (auth: E), E (auth: C), H (auth: K), J (auth: H)
Chain Length:247
Number of Molecules:4
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Antibody C05, light chain
Chain IDs:C (auth: F), F (auth: D), I (auth: L), K (auth: I)
Chain Length:214
Number of Molecules:4
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Multistate design of influenza antibodies improves affinity and breadth against seasonal viruses.
Proc. Natl. Acad. Sci. U.S.A. 116 1597 1602 (2019)
PMID: 30642961 DOI: 10.1073/pnas.1806004116

Abstact

Influenza is a yearly threat to global public health. Rapid changes in influenza surface proteins resulting from antigenic drift and shift events make it difficult to readily identify antibodies with broadly neutralizing activity against different influenza subtypes with high frequency, specifically antibodies targeting the receptor binding domain (RBD) on influenza HA protein. We developed an optimized computational design method that is able to optimize an antibody for recognition of large panels of antigens. To demonstrate the utility of this multistate design method, we used it to redesign an antiinfluenza antibody against a large panel of more than 500 seasonal HA antigens of the H1 subtype. As a proof of concept, we tested this method on a variety of known antiinfluenza antibodies and identified those that could be improved computationally. We generated redesigned variants of antibody C05 to the HA RBD and experimentally characterized variants that exhibited improved breadth and affinity against our panel. C05 mutants exhibited improved affinity for three of the subtypes used in design by stabilizing the CDRH3 loop and creating favorable electrostatic interactions with the antigen. These mutants possess increased breadth and affinity of binding while maintaining high-affinity binding to existing targets, surpassing a major limitation up to this point.

Legend

Protein

Chemical

Disease

Primary Citation of related structures